Achieve Life Sciences (ACHV) Misses Q2 EPS by 27c

Achieve Life Sciences (NASDAQ: ACHV) reported Q2 EPS of ($1.08), $0.27 worse than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• MongoDB stock tumbles despite earnings beat on profit-taking
• California Resources completes $63M acquisition of Crimson Midstream